We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Sanofi, GSK Commit 60 Million COVID-19 Vaccine Doses to UK
Sanofi, GSK Commit 60 Million COVID-19 Vaccine Doses to UK
Sanofi and GlaxoSmithKline have reached a deal with the British government that will secure up to 60 million doses of the drugmakers’ experimental COVID-19 vaccine for the UK.